Prevalence of and risk factors for oral human papillomavirus among youngwomen in costa rica

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1643-1652

  Kuhs, Krystle A Lang ^a   Gonzalez, Paula ^b,c   Struijk, Linda ^d   Castro, Felipe ^a   Hildesheim, Allan ^a   Van Doorn, Leen Ja ^d   Rodriguez, Ana Cecilia ^b   Schiffman, Mark ^a   Quint, Wim ^d   Lowy, Douglas R ^a   Porras, Carolina ^d   Delvecchio, Corey ^e   Katki, Hormuzd A ^a   Jimenez, Silvia ^b   Safaeian, Mahboobeh ^a   Schiller, John ^a   Solomon, Diane ^a   Wacholder, Sholom ^a   Herrero, Rolando ^c   Kreimer, Aimée R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d DDL DIAGNOSTIC LABORATORY   (Netherlands)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

Costa rica; Guanacaste; Hpv; Human papillomavirus vaccine; Oral HPV dna; Oropharynx cancer

Indexed keywords

HEPATITIS A VACCINE; WART VIRUS VACCINE;

ADULT; ANUS; ARTICLE; CARCINOGENICITY; CHRONIC SINUSITIS; CONTROLLED STUDY; COSTA RICA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MARRIAGE; MOUTH INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PHASE 3 CLINICAL TRIAL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; UTERINE CERVICITIS; VIRAL SKIN DISEASE; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

COSTA RICA; GUANACASTE; HPV; HUMAN PAPILLOMAVIRUS VACCINE; ORAL HPV DNA; OROPHARYNX CANCER;

ADULT; COSTA RICA; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; STOMATITIS; YOUNG ADULT;

EID: 84888612933     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit369     Document Type: Article

References (39)

1. Hocking JS, Stein A, Conway EL, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011; 104:886-91.
2. Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2011; 129:733-41.
3. Reddy VM, Cundall-Curry D, Bridger MW. Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985-2006. Ann R Coll Surg Engl 2010; 92:655-9.
4. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004; 57:449-55.
5. Ioka A, Tsukuma H, Ajiki W, Oshima A. Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol 2005; 35:45-7.
6. Braakhuis BJ, Visser O, Leemans CR. Oral and oropharyngeal cancer in the Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 2009; 45:e85-9.
7. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26:612-9.
8. Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012; 30(suppl 5):F34-54.
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-75.
10. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356:1944-56.
11. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012; 39:559-66.
12. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693-703.
13. Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011; 20:172-82.
14. Bottalico D, Chen Z, Dunne A, et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 2011; 204:787-92.
15. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur HH. Classification of papillomaviruses. Virology 2004; 324:17-27.
16. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401:70-9.
17. Kurose K, Terai M, Soedarsono N, et al. Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:91-6.
18. Paolini F, Rizzo C, Sperduti I, et al. Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancer. J Clin Virol 2013; 56:72-6.
19. Giraldo P, Goncalves AK, Pereira SA, Barros-Mazon S, Gondo ML, Witkin SS. Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions. Eur J Obstet Gynecol Reprod Biol 2006; 126:104-6.
20. do Sacramento PR, Babeto E, Colombo J, et al. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population. J Med Virol 2006; 78:614-8.
21. Tristao W, Ribeiro RM, Oliveira CA, Betiol JC, Bettini JS. Epidemiological study of HPV in oral mucosa through PCR. Braz J Otorhinolaryngol 2012; 78:66-70.
22. Ragin CC, Wheeler VW, Wilson JB, et al. Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers 2007; 12:510-22.
23. Esquenazi D, Bussoloti Filho I, Carvalho MG, Barros FS. The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz J Otorhinolaryngol 2010; 76:78-84.
24. Herrero R, Hildesheim A, Rodriguez AC, et al. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine 2008; 26:4795-808.
25. Lum A, Le ML. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 1998; 7:719-24.
26. Garcia-Closas M, Egan KM, Abruzzo J, et al. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 2001; 10:687-96.
27. Walsh DJ, Corey AC, Cotton RW, et al. Isolation of deoxyribonucleic acid (DNA) from saliva and forensic science samples containing saliva. J Forensic Sci 1992; 37:387-95.
28. Herrero R, Quint W, Hildesheim A, et al. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PloS one 2013; 8:e68329.
29. van Doorn LJ, Molijn A, Kleter B, Quint W, Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006; 44:3292-8.
30. de Koning M, Quint W, Struijk L, et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006; 44:1792-800.
31. de Koning M, ter Schegget J, Eekhof JA, et al. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types. J Clin Microbiol 2010; 48:1706-11.
32. Carr TF, Koterba AP, Chandra R, et al. Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis. Am J Rhinol Allergy 2011; 25:241-4.
33. Roberts JN, Buck CB, Thompson CD, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007; 13:857-61.
34. Kovanda A, Kocjan BJ, Luzar B, Bravo IG, Poljak M. Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151. PLoS One 2011; 6:e22529.
35. Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003; 41:2509-14.
36. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 11636-41.
37. Castellsague X, Drudis T, Canadas MP, et al. Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: A prospective study in Spain. BMC Infect Dis 2009; 9:74.
38. de Koning MN, Struijk L, Bavinck JN, et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88: 1489-95.
39. Cardoso JC, Calonje E. Cutaneous manifestations of human papillomaviruses: A review. Acta Dermatovenerol Alp Panonica Adriat 2011; 20: 145-54.